Skip to main content
Premium Trial:

Request an Annual Quote

DakoCytomation s CyAn ADP (Advanced Digital Processing) and Research and Markets Cellular Assays 2004


DakoCytomation last week said that it has started to ship its new CyAn ADP (Advanced Digital Processing) instrument platform for flow cytometry analysis.

DakoCytomation said that the ADP enables high-speed analysis on a 12 in. X 18 in. X 16 in. (30 cm X 45 cm X 40 cm) footprint, and that the instrument comes with new Summit Software version 4.1. The CyAn is available in three models, each offering an individual laser and color configuration for applications such as stem cell/SP analysis, CD34 enumeration, signal transduction, antigen-specific T-cells, and multi-color immunophenotyping, the company said.

Research and Markets has announced the addition of Cellular Assays 2004 to its collection of life sciences and biotechnology research reports.

The new report includes analysis and end-user perspectives on current cellular assays technologies and applications, Research and Markets said. The report integrates case studies, company profiles, market trends, and challenges and strategic options for cellular assay companies seeking market opportunities, Research and Markets said.

Further information on the report can be obtained by visiting

The Scan

Quality Improvement Study Compares Molecular Tumor Boards, Central Consensus Recommendations

With 50 simulated cancer cases, researchers in JAMA Network Open compared molecular tumor board recommendations with central consensus plans at a dozen centers in Japan.

Lupus Heterogeneity Highlighted With Single-Cell Transcriptomes

Using single-cell RNA sequencing, researchers in Nature Communications tracked down immune and non-immune cell differences between discoid lupus erythematosus and systemic lupus erythematosus.

Rare Disease Clues Gleaned From Mobile Element Insertions in Exome Sequences

With an approach called MELT, researchers in the European Journal of Human Genetics uncovered mobile element insertions in exomes from 3,232 individuals with or without developmental or neurological abnormalities.

Team Tracks Down Potential Blood Plasma Markers Linked to Heart Failure in Atrial Fibrillation Patients

Researchers in BMC Genomics found 10 differentially expressed proteins or metabolites that marked atrial fibrillation with heart failure cases.